What is the price target for FEMY stock?
9 analysts have analysed FEMY and the average price target is 5.27 USD. This implies a price increase of 845.47% is expected in the next year compared to the current price of 0.5574.
NASDAQ:FEMY • US31447E1055
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for FEMASYS INC (FEMY).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-03 | Lake Street | Initiate | Buy |
| 2025-11-20 | Laidlaw & Co. | Initiate | Buy |
| 2025-08-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-13 | Jones Trading | Maintains | Buy -> Buy |
| 2025-05-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-08-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-01 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-04-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.21M 2.54% | 1.072M -11.40% | 1.629M 51.97% | 2.598M 59.47% | 6.509M 150.54% | 19.319M 196.80% | 45.732M 136.72% | 82.021M 79.35% | 139.55M 70.14% | 199.58M 43.02% | 274.04M 37.31% | 319.87M 16.72% | |
| EBITDA YoY % growth | -11.04M -42.45% | -14.025M -27.04% | -17.489M -24.70% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -11.6M -39.09% | -14.508M -25.07% | -17.786M -22.59% | -16.755M 5.80% | -19.186M -14.51% | -16.408M 14.48% | 2.456M 114.97% | 29.523M 1,102.08% | 77.376M 162.09% | 124.75M 61.23% | 183.13M 46.80% | 199.95M 9.18% | |
| Operating Margin | -958.68% | -1,353.40% | -1,091.76% | -644.91% | -294.76% | -84.93% | 5.37% | 35.99% | 55.45% | 62.51% | 66.83% | 62.51% | |
| EPS YoY % growth | -0.96 -28.05% | -0.92 4.17% | -0.85 7.61% | -0.56 33.60% | -0.37 33.73% | -0.28 25.00% | -0.26 9.09% | 0.03 112.00% | 0.65 2,033.33% | 1.29 96.88% | 2.19 70.63% | 3.00 36.74% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.09 61.20% | -0.09 60.09% | -0.08 45.60% | -0.09 8.20% | -0.09 -2.86% |
| Revenue Q2Q % growth | 1.321M 126.98% | 2.111M 518.59% | 2.203M 369.72% | 2.387M 227.43% | 2.479M 87.66% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.512M 25.63% | -5.209M 4.60% | -5.436M -41.13% | -5.888M -61.16% | -6.115M -74.11% |
All data in USD
9 analysts have analysed FEMY and the average price target is 5.27 USD. This implies a price increase of 845.47% is expected in the next year compared to the current price of 0.5574.
FEMASYS INC (FEMY) will report earnings on 2026-03-26, after the market close.
The consensus EPS estimate for the next earnings of FEMASYS INC (FEMY) is -0.09 USD and the consensus revenue estimate is 1.32M USD.
The consensus rating for FEMASYS INC (FEMY) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.